These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2852999)

  • 61. In vitro and in vivo expression of opioid and sigma receptors in rat C6 glioma and mouse N18TG2 neuroblastoma cells.
    Barg J; Thomas GE; Bem WT; Parnes MD; Ho AM; Belcheva MM; McHale RJ; McLachlan JA; Tolman KC; Johnson FE
    J Neurochem; 1994 Aug; 63(2):570-4. PubMed ID: 8035181
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MK-801 stimulates the release of adrenocorticotrophin but not does affect the release of prolactin in the rat.
    Pechnick RN; George R; Poland RE
    Eur J Pharmacol; 1987 Sep; 141(2):323-4. PubMed ID: 2824221
    [No Abstract]   [Full Text] [Related]  

  • 64. Different role of opiate mu-, delta-, kappa- and sigma-receptors in modification of habituation of orthodromic evoked potential in the turtle's visual cortex.
    Pivovarov AS; Izmestyev VI
    Brain Res; 1984 May; 300(2):257-73. PubMed ID: 6329433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons.
    Steinfels GF; Tam SW; Cook L
    Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study.
    Nimura T; Ando T; Yamaguchi K; Nakajima T; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2004 Apr; 100(4):606-10. PubMed ID: 15070112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diversified electrophysiological properties of morphinan drugs in rats.
    Sagratella S; Zeng YC; Frank C; de Carolis AS
    Gen Pharmacol; 1991; 22(2):231-6. PubMed ID: 1647341
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The sigma ligand 1,3-di-o-tolylguanidine depresses amino acid-induced excitation non-selectively in rat brain.
    Connick JH; Addae JI; Nicholson CD; Stone TW
    Eur J Pharmacol; 1992 Apr; 214(2-3):169-73. PubMed ID: 1325354
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Species differences in mu- and delta-opioid receptors.
    Yoburn BC; Lutfy K; Candido J
    Eur J Pharmacol; 1991 Jan; 193(1):105-8. PubMed ID: 1646725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE; Stoessl AJ
    Neuroscience; 2002; 112(4):851-9. PubMed ID: 12088744
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
    Holtzman SG
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1054-62. PubMed ID: 2539453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.
    Iwamoto ET
    J Pharmacol Exp Ther; 1981 May; 217(2):451-60. PubMed ID: 6262485
    [No Abstract]   [Full Text] [Related]  

  • 73. Clinical evidence for different narcotic receptors and relevance for the clinician.
    Martin WR
    Ann Emerg Med; 1986 Sep; 15(9):1026-9. PubMed ID: 3017158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
    Waddington JL; Cross AJ; Gamble SJ; Bourne RC
    Adv Biochem Psychopharmacol; 1983; 37():299-308. PubMed ID: 6138952
    [No Abstract]   [Full Text] [Related]  

  • 75. Sigma receptor ligands alter concentrations of corticosterone in plasma in the rat.
    Matheson GK; Guthrie D; Bauer C; Knowles A; White G; Ruston C
    Neuropharmacology; 1991 Jan; 30(1):79-87. PubMed ID: 1675451
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sigma receptors are highly concentrated in the rat pineal gland.
    Jansen KL; Dragunow M; Faull RL
    Brain Res; 1990 Jan; 507(1):158-60. PubMed ID: 2154298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differentiation of phencyclidine and sigma receptor types affecting the central inspiratory termination mechanism in cat.
    Foutz AS; Denavit-Saubié M
    Life Sci; 1989; 45(14):1285-92. PubMed ID: 2554082
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Altered receptor sensitivity following chronic drug administration in man: the tardive dyskinesia model [proceedings].
    Rubovits R
    Psychopharmacol Bull; 1977 Jan; 13(1):49-50. PubMed ID: 402011
    [No Abstract]   [Full Text] [Related]  

  • 79. Opioid receptor affinity for agonist-antagonist analgesics.
    Jacobs AM; Youngblood F
    J Am Podiatr Med Assoc; 1992 Oct; 82(10):520-4. PubMed ID: 1361946
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Autoradiographic localization of the phencyclidine/sigma "opiate" receptor in rat brain.
    Quirion R; Hammer RP; Herkenham M; Pert CB
    NIDA Res Monogr; 1982 Apr; 41():178-83. PubMed ID: 6289117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.